Assenagon Asset Management S.A. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Assenagon Asset Management S.A. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$57,000
-94.9%
26,362
-92.1%
0.00%
-100.0%
Q3 2021$1,124,000
-70.1%
334,589
-34.4%
0.00%
-83.3%
Q2 2020$3,761,000
+950.6%
510,302
+325.0%
0.02%
+700.0%
Q1 2020$358,000
+30.7%
120,060
+82.2%
0.00%
+50.0%
Q4 2019$274,00065,9060.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders